Envarsus XR 0.75 mg 24HR Extended Release Oral Tablet
RxNorm 1664458
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1664458 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Envarsus XR 0.75 mg 24HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
24 HR Envarsus 0.75 mg Extended Release Oral Tablet
(Atom ID: 7266757)
SBDPrescribable
Semantic Branded Drug (SBD):
24 HR tacrolimus 0.75 mg Extended Release Oral Tablet [Envarsus]
(Atom ID: 12361378)
PSNPrescribable
Prescribable Name (PSN):
Envarsus XR 0.75 mg 24HR Extended Release Oral Tablet
(Atom ID: 7266756)
SYPrescribable
Synonym (SY):
Envarsus XR 0.75 mg 24HR Extended Release Oral Tablet
(Atom ID: 7266758)
Patient Education
Tacrolimus
Tacrolimus (Astagraf XL, Envarsus XR, Prograf) is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received a kidney transplant. Tacrolimus (Prograf) is also used along with other medications to prevent rejection in people who have received a liver or heart transplant. Tacrolimus is in a class of medications called immunosupressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ.
[Learn More]
* Please review the disclaimer below.